Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening

Pediatric Pulmonology

Volumn 35, Issue 4, 2003, Pages 257-262

  Maselli, Judith H ^a   Sontag, Marci K ^b   Norris, Jill M ^a   MacKenzie, Todd ^a   Wagener, Jeff S ^b   Accurso, Frank J ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Acquisition; Cystic fibrosis; Pseudomonas aeruginosa; Risk factors

Indexed keywords

ANAMNESIS; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; COVARIANCE; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; GENDER; GENOTYPE; HAZARD ASSESSMENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIVARIATE ANALYSIS; NEWBORN SCREENING; OROPHARYNX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TIME;

CHILD; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; NEONATAL SCREENING; PROPORTIONAL HAZARDS MODELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; SEX FACTORS;

EID: 12244306198     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10230     Document Type: Article

References (25)

1. Kerem E. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers. Pediatr Pulmonol [Suppl] 1997;16:265-266.
2. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
3. Pedersen SS, Høiby N, Espersen F, Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 1992;47:6-13.
4. Davis PB. The gender gap in cystic fibrosis survival. J Gender Specific Med 1999;2:47-51.
5. Grothues D, Koopmann U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988;26:1973-1977.
6. Pedersen SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 1986;17:505-516.
7. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177-181.
8. Hunfeld KP, Schmidt C, Krackhardt B, Posselt HG, Bargon J, Yahaf Y, Schafer V, Brade V, Wichelhaus TA. Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp - a molecular-epidemiological study. Wien Klin Wochenschr 2000;112:329-333.
9. Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonizationin cystic fibrosis patients. Pediatr Infect Dis J 1990;9:494-498.
10. Wang S, Fitzsimmons SC, O'Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and the risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: a registry-based longitudinal study. Pediatrics 2001;107:274-279.
11. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100:2.
12. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998;26:81-88.
13. Demko CA, Byard PJ, Davis P. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-1049.
14. Hammond KB, Abman SH, Sokol RJ, Accurso FJ. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med 1991;325:769-774.
15. Abman SH, Ogle JW, Harbeck RJ, Butler-Simon N, Hammond KB, Accurso FJ. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr 1991;119:211-217.
16. Rommens J, Kerem BS, Greer W, Chang P, Tsui LC, Ray P. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990;46:395-396.
17. Gibson LF, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis. Pediatrics 1959;23:545.
18. Allison PD. Estimating Cox regression models with Proc Phreg. In: Survival analysis using the SAS system. Cary, NC: SAS Institute, Inc.; 1995. p 138-157.
19. Fitzsimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
20. Mohon RT, Wagener JS, Abman SH, Seltzer WK, Accurso FJ. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J Pediatr 1993;122:550-555.
21. Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for AF508 mutation. Lancet 1991;337:631-634.
22. Zar H, Saiman L, Quittell L, Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr 1995;126:230-233.
23. Kubesch P, Dork T, Wulbrand U, Kalin N, Neumann T, Wulf B, Geerlings H, Weissbrodt H, von der Hardt H, Tummler B. Genetic determinants of airways' colonization with Pseudomonas aeruginosa in cystic fibrosis. Lancet 1993;341:189-193.
24. De Braekeleer M, Allard C, Leblanc JP, Aubin G, Simard F. Genetic determinants of Pseudomonas aeruginosa colonization in cystic fibrosis patients in Canada. Eur J Clin Microbiol Infect Dis 1998;17:269-271.
25. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, Wagener J. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-328.